NO981748L - Nytt DNA, samt en fremgangsmÕte for fremstilling av protein ved anvendelse av dette - Google Patents
Nytt DNA, samt en fremgangsmÕte for fremstilling av protein ved anvendelse av detteInfo
- Publication number
- NO981748L NO981748L NO981748A NO981748A NO981748L NO 981748 L NO981748 L NO 981748L NO 981748 A NO981748 A NO 981748A NO 981748 A NO981748 A NO 981748A NO 981748 L NO981748 L NO 981748L
- Authority
- NO
- Norway
- Prior art keywords
- well
- new dna
- protein
- producing protein
- producing
- Prior art date
Links
- 102000004169 proteins and genes Human genes 0.000 title abstract 4
- 108090000623 proteins and genes Proteins 0.000 title abstract 4
- 108020004414 DNA Proteins 0.000 abstract 2
- 108091028043 Nucleic acid sequence Proteins 0.000 abstract 1
- 208000001132 Osteoporosis Diseases 0.000 abstract 1
- 230000015572 biosynthetic process Effects 0.000 abstract 1
- 239000013604 expression vector Substances 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 210000002997 osteoclast Anatomy 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Wood Science & Technology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Plant Pathology (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Crystallography & Structural Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Toxicology (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Gastroenterology & Hepatology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Saccharide Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP8235928A JPH1057071A (ja) | 1996-08-19 | 1996-08-19 | 新規ｄｎａ及びそれを用いた蛋白質の製造方法 |
| PCT/JP1997/002859 WO1998007840A1 (fr) | 1996-08-19 | 1997-08-19 | Nouveaux adn et procede de production de proteines a l'aide de ces derniers |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO981748D0 NO981748D0 (no) | 1998-04-17 |
| NO981748L true NO981748L (no) | 1998-06-18 |
Family
ID=16993321
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO981748A NO981748L (no) | 1996-08-19 | 1998-04-17 | Nytt DNA, samt en fremgangsmÕte for fremstilling av protein ved anvendelse av dette |
Country Status (12)
| Country | Link |
|---|---|
| EP (1) | EP0874045A1 (zh) |
| JP (1) | JPH1057071A (zh) |
| KR (1) | KR20000064276A (zh) |
| CN (1) | CN1198776A (zh) |
| AU (1) | AU718458B2 (zh) |
| CA (1) | CA2235148A1 (zh) |
| FI (1) | FI980853A (zh) |
| HU (1) | HUP0001837A3 (zh) |
| NO (1) | NO981748L (zh) |
| NZ (1) | NZ330400A (zh) |
| WO (1) | WO1998007840A1 (zh) |
| ZA (1) | ZA977402B (zh) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL117175A (en) | 1995-02-20 | 2005-11-20 | Sankyo Co | Osteoclastogenesis inhibitory factor protein |
| US6919434B1 (en) | 1995-02-20 | 2005-07-19 | Sankyo Co., Ltd. | Monoclonal antibodies that bind OCIF |
| ES2144386T5 (es) | 1996-12-23 | 2012-12-07 | Immunex Corporation | Ligando para el activador del receptor de NF-kappa b, el ligando es miembro de la superfamilia de TNF |
| CA2781623A1 (en) | 1997-04-15 | 1998-10-22 | Daiichi Sankyo Company, Limited | Novel protein binding to osteoclastogenesis inhibitory factor and process for producing the same |
| SI0975754T2 (sl) | 1997-04-16 | 2016-04-29 | Amgen Inc., | Vezivni proteini in receptorji osteoprotegerina |
| US6316408B1 (en) | 1997-04-16 | 2001-11-13 | Amgen Inc. | Methods of use for osetoprotegerin binding protein receptors |
| ATE328281T1 (de) | 1997-09-24 | 2006-06-15 | Sankyo Co | Methode zur diagnose von abnormalem knochenstoffwechsel |
| AU762574B2 (en) | 1998-05-14 | 2003-06-26 | Immunex Corporation | Method of inhibiting osteoclast activity |
| NZ511506A (en) | 1998-10-28 | 2004-02-27 | Sankyo Co | Remedies for bone metabolic errors comprising OCIF |
| AUPQ167599A0 (en) * | 1999-07-19 | 1999-08-12 | St. Vincent's Institute Of Medical Research | Inhibitor of osteoclast precursor formation |
| WO2001023562A2 (en) * | 1999-09-27 | 2001-04-05 | Eli Lilly And Company | Osteoprotegerin regulatory region |
| DE60235418D1 (de) | 2001-04-03 | 2010-04-01 | Nestle Sa | Osteoprotegerin in Milch |
| KR100942393B1 (ko) | 2001-05-25 | 2010-02-17 | 휴먼 게놈 사이언시즈, 인코포레이티드 | Ｔｒａｉｌ 수용체에 면역특이적으로 결합하는 항체 |
| EP2314316A1 (en) | 2002-04-05 | 2011-04-27 | Amgen, Inc | Human anti-OPGL neutralizing antibodies as selective OPGL pathway inhibitors |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL117175A (en) * | 1995-02-20 | 2005-11-20 | Sankyo Co | Osteoclastogenesis inhibitory factor protein |
| US6369027B1 (en) * | 1995-12-22 | 2002-04-09 | Amgen Inc. | Osteoprotegerin |
-
1996
- 1996-08-19 JP JP8235928A patent/JPH1057071A/ja not_active Withdrawn
-
1997
- 1997-08-18 ZA ZA977402A patent/ZA977402B/xx unknown
- 1997-08-19 CA CA002235148A patent/CA2235148A1/en not_active Abandoned
- 1997-08-19 KR KR1019980702740A patent/KR20000064276A/ko not_active Application Discontinuation
- 1997-08-19 HU HU0001837A patent/HUP0001837A3/hu unknown
- 1997-08-19 EP EP97935810A patent/EP0874045A1/en not_active Withdrawn
- 1997-08-19 CN CN97191093A patent/CN1198776A/zh active Pending
- 1997-08-19 AU AU38661/97A patent/AU718458B2/en not_active Ceased
- 1997-08-19 WO PCT/JP1997/002859 patent/WO1998007840A1/ja not_active Application Discontinuation
-
1998
- 1998-04-17 FI FI980853A patent/FI980853A/fi unknown
- 1998-04-17 NO NO981748A patent/NO981748L/no unknown
- 1998-05-07 NZ NZ330400A patent/NZ330400A/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| HUP0001837A3 (en) | 2002-09-30 |
| MX9803086A (es) | 1998-11-29 |
| AU718458B2 (en) | 2000-04-13 |
| AU3866197A (en) | 1998-05-11 |
| ZA977402B (en) | 1999-02-18 |
| EP0874045A1 (en) | 1998-10-28 |
| JPH1057071A (ja) | 1998-03-03 |
| FI980853A (fi) | 1998-06-15 |
| EP0874045A4 (zh) | 1998-11-18 |
| WO1998007840A1 (fr) | 1998-02-26 |
| NZ330400A (en) | 1999-05-28 |
| HUP0001837A2 (hu) | 2000-09-28 |
| CA2235148A1 (en) | 1998-02-26 |
| CN1198776A (zh) | 1998-11-11 |
| KR20000064276A (ko) | 2000-11-06 |
| NO981748D0 (no) | 1998-04-17 |
| FI980853A0 (fi) | 1998-04-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO981748L (no) | Nytt DNA, samt en fremgangsmÕte for fremstilling av protein ved anvendelse av dette | |
| LTIP828A (en) | Nucleic acid fragment which codes for human proapolipoprotein a-1 | |
| BR9814404A (pt) | " clonagem de expressão em fungos filamentosos " | |
| ATE239090T1 (de) | Methode zum generieren von einzelsträngigen dna molekülen | |
| BR0106682A (pt) | Molécula de anticorpo, variante de molécula de anticorpo, anticorpo, composto, sequência de dna, vetor de clonagem ou de expressão, vetor de expressão de e. coli, célula hospedeira, processo para a produção da molécula de anticorpo, composição terapêutica ou diagnóstica, uso da molécula de anticorpo, vetorpdnabeng-g1, vetorptto(cdp870), e, polipeptìdeo | |
| DK0698105T3 (da) | Nukleotidsekvenser til styring af ekspressionen af DNAsekvenser i en værtscelle | |
| AU2002339458A1 (en) | Sirna knockout assay method and constructs | |
| DK338788D0 (da) | Fremgangsmaade til transformering af celler | |
| GB9722320D0 (en) | Human cell cycle checkpoint proteins | |
| DE69840333D1 (de) | 2-m übergang des zellzyklus | |
| WO1995006735A3 (en) | Nucleotide sequences for novel protein tyrosine phosphatases | |
| AU3230797A (en) | Dna encoding dp. 75 and a process for its use | |
| WO1998006841A3 (en) | Two human nsp-like proteins | |
| Pettijohn | Ordered and preferential initiation of ribosomal RNA synthesis in vitro | |
| BR0317537A (pt) | Processo para preparar aminoácidos em organismos transgênicos, construção de ácido nucleico, vetor, organismo procariótico ou eucariótico transgênico, uso dos organismos transgênicos, e, sequencia de aminoácidos | |
| DE60126802D1 (de) | Cyclopeptide, verfahren zu ihrer herstellung und ihre verwendung zur hemmung oder stimulierung von angiogenese | |
| Lanzendörfer et al. | Structure and function of the DNA-dependent RNA polymerase of Sulfolobus | |
| WO1998027200A3 (en) | Human and mammalian dna replication origin consensus sequences | |
| Crawford et al. | DNA sequence of the tryptophan synthase genes of Pseudomonas putida | |
| WO2000024765A8 (en) | Chlamydia antigens and corresponding dna fragments and uses thereof | |
| Biswas et al. | DNA helicase associated with DNA polymerase. alpha.: Isolation by a modified immunoaffinity chromatography | |
| WO2000065062A3 (fr) | Sequence genomique et polypeptides de pyrococcus abissy, leurs fragments et leurs utilisations | |
| Govil et al. | Recognition schemes for protein-nucleic acid interactions | |
| NZ333988A (en) | isolated DNA molecule encoding mycobacterial proteins associated with cell binding and cell entry and uses thereof having a molecular weight of 45 to 60 kDa | |
| Amblar et al. | Purification and properties of the 5′-3′ exonuclease D10A mutant of DNA polymerase I from Streptococcus pneumoniae: a new tool for DNA sequencing |